DOI QR코드

DOI QR Code

Is there any Potential Clinical Impact of Serum Phosphorus and Magnesium in Patients with Lung Cancer at First Diagnosis? A Multi-institutional Study

  • Kouloulias, Vassilis (2nd Department of Radiology, Radiotherapy Unit, Medical School, National Kapodistrian University of Athens) ;
  • Tolia, Maria (2nd Department of Radiology, Radiotherapy Unit, Medical School, National Kapodistrian University of Athens) ;
  • Tsoukalas, Nikolaos (Medical Oncology Department, 401 Military Hospital) ;
  • Papaloucas, Christos (Radiotherapy Department, AHEPA University Hospital, Medical School) ;
  • Pistevou-Gombaki, Kyriaki (Radiotherapy Department, AHEPA University Hospital, Medical School) ;
  • Zygogianni, Anna (1st Department of Radiology, Radiotherapy Unit, Medical School, National Kapodistrian University of Athens) ;
  • Mystakidou, Kyriaki (1st Department of Radiology, Radiotherapy Unit, Medical School, National Kapodistrian University of Athens) ;
  • Kouvaris, John (1st Department of Radiology, Radiotherapy Unit, Medical School, National Kapodistrian University of Athens) ;
  • Papaloucas, Marios (Anti-doping Committee, University of Pelloponissos) ;
  • Psyrri, Amanda (Medical Oncology Unit, Attikon University Hospital) ;
  • Kyrgias, George (Radiotherapy Department, Larissa University Hospital) ;
  • Gennimata, Vasiliki (Department of Microbiology, Medical School of Athens) ;
  • Leventakos, Konstantinos (2nd Department of Pathology, Medical School of Athens) ;
  • Panayiotides, Ioannis (2nd Department of Pathology, Medical School of Athens) ;
  • Liakouli, Zoi (1st Department of Radiology, Radiotherapy Unit, Medical School, National Kapodistrian University of Athens) ;
  • Kelekis, Nikolaos (2nd Department of Radiology, Radiotherapy Unit, Medical School, National Kapodistrian University of Athens) ;
  • Papaloucas, Aristofanis (Aristotelis University)
  • 발행 : 2015.02.04

초록

Background: The aim of the study was to determine whether the expression of baseline phosphorus (P) and magnesium (Mg) levels were prognostic in terms of stage and overall survival (OS) in newly diagnosed non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) patients. Materials and Methods: Retrospectively, 130 patients were selected at the time of diagnosis oflung cancer (100 with NSCLC and 30 with SCLC), before the initialization of any chemo-radiotherapy. The median age was 67 (range 29-92). IA, IB, IIA, IIB, IIIA, IIIB and IV stages were present in 3, 4, 19, 6, 25, 8, and 65 patients, respectively. After centrifugation, the levels of serum P and Mg were measured using the nephelometric method/ photometry and evaluated before any type of treatment. Results: Higher than normal levels of P were found in 127/130 patients, while only four patients had elevated Mg serum values. In terms of Spearman test, higher P serum values correlated with either stage (rho=- 0.334, p<0.001) or OS (rho=-0.212, p=0.016). Additionally, a significant negative correlation of Mg serum levels was found with stage of disease (rho=-0.135, P=0.042). On multivariate cox-regression survival analysis, only stage (p<0.01), performance status (p<0.01) and P serum (p=0.045) showed a significant prognostic value. Conclusions: Our study indicated that pre-treatment P serum levels in lung cancer patients are higher than the normal range. Moreover, P and Mg serum levels are predictive of stage of disease. Along with stage and performance status, the P serum levels had also a significant impact on survival. This information may be important for stratifying patients to specific treatment protocols or intensifying their therapies. However, larger series are now needed to confirm our results.

키워드

참고문헌

  1. Amanzadeh J, Reilly RF (2006). Hypophosphatemia: an evidence-based approach to its clinical consequences and management. Nat Clin Pract Neph, 2, 136-48.
  2. Arslan D, Bozcuk H, Gunduz S, et al (2014). Survival results and prognostic factors in T4 N0-3 non-small cell lung cancer patients according to the AJCC 7th edition staging system. Asian Pac J Cancer Prev, 15, 2465-72. https://doi.org/10.7314/APJCP.2014.15.6.2465
  3. Babacan NA, Yucel B, Kilickap S, et al (2014). Lung cancer in women: a single institution experience with 50 patients. Asian Pac J Cancer Prev, 15, 151-4. https://doi.org/10.7314/APJCP.2014.15.1.151
  4. Bertuzzi A, Faretta M, Gandolfi A, et al (2002). Kinetic heterogeneity of an experimental tumour revealed by BrdUrd incorporation and mathematical modeling. Bull Math Biol, 64, 355-84. https://doi.org/10.1006/bulm.2001.0280
  5. Bussiere FI, Gueux E, Rock E, Mazur A, Rayssiguier Y (2002). Protective effect of calcium deficiency on the inflammatory response in magnesium-deficient rats. Eur J Nutr, 41, 197-202. https://doi.org/10.1007/s00394-002-0376-0
  6. Cobanoglu U, Demir H, Sayir F, Duran M, Mergan D (2010). Some mineral, trace element and heavy metal concentrations in lung cancer. Asian Pac J Cancer Prev, 11, 1383-8.
  7. Dai Q, Motley SS, Smith JA Jr, et al (2011). Blood magnesium, and the interaction with calcium, on the risk of high-grade prostate cancer. PLoS One, 6, 18237. https://doi.org/10.1371/journal.pone.0018237
  8. Dai Q, Motley SS, Smith JA Jr, et al (2011). Blood magnesium, and the interaction with calcium, on the risk of high-grade prostate cancer. PLoS One, 6, 18237. https://doi.org/10.1371/journal.pone.0018237
  9. De Carvalho CC, Caramujo MJ (2012). Tumour metastasis as an adaptation of tumour cells to fulfil their phosphorus requirements. Med Hypotheses, 78, 664-7. https://doi.org/10.1016/j.mehy.2012.02.006
  10. Demir C, Demir H, Esen R, et al (2011). Altered serum levels of elements in acute leukemia cases in Turkey. Asian Pac J Cancer Prev, 12, 3471-4.
  11. Elser JJ, Kyle MM, Smith MS, Nagy JD (2007). Biological stoichiometry in human cancer. PLoS ONE, 2, 1028. https://doi.org/10.1371/journal.pone.0001028
  12. Ettinger DS (2012). Ten years of progress in non-small cell lung cancer. J Natl Compr Canc Netw, 10, 292-95.
  13. Firat S, Byhardt RW, Gore E (2002). Comorbidity and karnofksy performance score are independent prognostic factors in stage III non-small-cell lung cancer: an institutional analysis of patients treated on four RTOG studies. radiation therapy oncology group. Int J Radiat Oncol Biol Phys, 54, 357-64. https://doi.org/10.1016/S0360-3016(02)02939-5
  14. Gryshkova V, Goncharuk I, Gurtovyy V, et al (2009). The study of phosphate transporter NAPI2B expression in different histological types of epithelial ovarian cancer. Exp Oncol, 31, 37-42
  15. Howlader N, Noone AM, Krapcho M, et al (2009). SEER cancer statistics review, 1975-2009 (vintage 2009 populations), National Cancer Institute. Bethesda, MD.
  16. ICRU Report 50, 62: Prescribing, recording and reporting photon beam therapy. 1993,1999.
  17. Inal A, Kaplan MA, Kucukoner M, et al (2012). Prognostic factors in first-line chemotherapy treated metastatic gastric cancer patients: a retrospective study. Asian Pac J Cancer Prev, 13, 3869-72. https://doi.org/10.7314/APJCP.2012.13.8.3869
  18. Iseri LT, French JH (1984). Magnesium: nature's physiologic calcium blocker. Am Heart J, 108, 188-93. https://doi.org/10.1016/0002-8703(84)90572-6
  19. Kaya V, Yildirim M, Demirpence O, Yildiz M, Yalcin AY (2013). Prognostic significance of basic laboratory methods in nonsmall-cell-lung cancer. Asian Pac J Cancer Prev, 14, 5473-6. https://doi.org/10.7314/APJCP.2013.14.9.5473
  20. Kenney JM, Marinelli LD, Woodard HQ (1941). Tracer studies with radioactive phosphorus in malignant neoplastic disease. Radiology, 37, 683-7. https://doi.org/10.1148/37.6.683
  21. Kouloulias V, Zygogianni A, Efstathopoulos E, et al (2013). Suggestion for a new grading scale for radiation induced pneumonitis based on radiological findings of computerized tomography: correlation with clinical and radiotherapeutic parameters in lung cancer patients. Asian Pac J Cancer Prev, 14, 2717-22. https://doi.org/10.7314/APJCP.2013.14.5.2717
  22. Kuang Y, Nagy JD, Elser JJ (2004). Biological stoichiometry of tumor dynamics: mathematical models and analysis. Discret Contin Dyn S-Series B, 4, 221-40.
  23. Kumar R (2000). Tumor-induced osteomalacia and the regulation of phosphate homeostasis. Bone, 27, 333-8. https://doi.org/10.1016/S8756-3282(00)00334-3
  24. Leone N, Courbon D, Ducimetiere P, Zureik M (2006). Zinc, copper, and magnesium and risks for all-cause, cancer, and cardiovascular mortality. Epidemiology, 17, 308-14. https://doi.org/10.1097/01.ede.0000209454.41466.b7
  25. Low-Beer B (1946). Surface measurements of radioactive phosphorus in breast tumours as a possible diagnostic method. Science, 104, 399.
  26. Marinelli lD, Goldschmidt B (1942). The concentration of P32 in some superficial tissues of living patients. Radiology, 39, 454-63. https://doi.org/10.1148/39.4.454
  27. Marshak A (1940). Uptake of radioactive phosphorus by nuclei of liver and tumors. Science, 92, 460-1. https://doi.org/10.1126/science.92.2394.460
  28. National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology (2014). http://www.nccn.org/professionals/physician.
  29. Oven Ustaalioglu BB, Unal OU, Turan N, et al (2013). Prognostic factors for lymph node negative stage I and IIA non-small cell lung cancer: multicenter experiences. Asian Pac J Cancer Prev, 14, 6287-92. https://doi.org/10.7314/APJCP.2013.14.11.6287
  30. Papaloucas CD, Papaloucas MD, Kouloulias V, et al (2013). Measurement of blood phosphorus: A quick and inexpensive method for detection of the existence of cancer in the body. Too good to be true, or forgotten knowledge of the past? Med Hypotheses, 82, 24-5.
  31. Papaloukas A (1958). Selective uptake of 32 P by the cervix in patients with carcinoma before and after treatment and in normal subjects. Br J Cancer, 12, 342-5. https://doi.org/10.1038/bjc.1958.41
  32. Pertzoff V, Gemmill CL (1949). The effect of anaesthetics on the uptake of radioactive Phosphorus by human erythrocytes. J Pharmacol Exper Therap, 95,106-15.
  33. Plataniotis GA, Kouvaris JR, Dardoufas C, et al (2002). A short radiotherapy course for locally advanced non-small cell lung cancer (NSCLC): effective palliation and patients' convenience. Lung Cancer, 35, 203-7. https://doi.org/10.1016/S0169-5002(01)00327-0
  34. Podd D (2010). Hyperphosphatemia: understanding the role of phosphate metabolism. JAAPA, 23, 32-7.
  35. Reck M, Thatcher N, Smit EF, et al (2012). Baseline quality of life and performance status as prognostic factors in patients with extensive-stage disease small cell lung cancer treated with pemetrexed plus carboplatin vs etoposide plus carboplatin. Lung Cancer, 78, 276-81. https://doi.org/10.1016/j.lungcan.2012.09.002
  36. Seri LT, French JH (1984). Magnesium: nature's physiologic calcium blocker. Am Heart J, 108, 188-93. https://doi.org/10.1016/0002-8703(84)90572-6
  37. Siegel R, Naishadham D, Jemal A (2012). Cancer statistics. CA Cancer J Clin, 62, 10-29. https://doi.org/10.3322/caac.20138
  38. Sommer S, Berndt T, Craig T, Kumar R (2007). The phosphatonins and the regulation of phosphate transport and vitamin D metabolism. J Steroid Biochem Mol Biol, 103, 497-503. https://doi.org/10.1016/j.jsbmb.2006.11.010
  39. Song XY, Zhou SJ, Xiao N, et al (2013). Research on the relationship between serum levels of inflammatory cytokines and non-small cell lung cancer. Asian Pac J Cancer Prev, 14, 4765-8. https://doi.org/10.7314/APJCP.2013.14.8.4765
  40. Sorensen HT, Friis S, Olsen JH, et al (1998). Risk of breast cancer in men with liver cirrhosis. Am J Gastroenterol, 93, 231-33. https://doi.org/10.1111/j.1572-0241.1998.00231.x
  41. Spira A, Beane J, Shah V, et al (2004). Effects of cigarette smoke on the human airway epithelial cell transcriptome. Proc Natl Acad Sci USA, 101, 10143-8. https://doi.org/10.1073/pnas.0401422101
  42. Wolf FI, Maier JA, Nasulewicz A, et al (2007). Magnesium and neoplasia: From carcinogenesis to tumor growth and progression or treatment. Arch Biochem Biophys, 458, 24-32. https://doi.org/10.1016/j.abb.2006.02.016

피인용 문헌

  1. Exchange Phenomena in the Electron Paramagnetic Resonance Spectra of the Nitroxyl and Trityl Radicals: Multifunctional Spectroscopy and Imaging of Local Chemical Microenvironment vol.89, pp.9, 2017, https://doi.org/10.1021/acs.analchem.6b03796
  2. Interstitial Inorganic Phosphate as a Tumor Microenvironment Marker for Tumor Progression vol.7, pp.1, 2017, https://doi.org/10.1038/srep41233